T6	Subject 40 56	myeloma patients
T8	Treatment 25 36;67 78	doxorubicin thalidomide
T7	Effect 0 21	Thrombogenic activity
T10	Treat-Disorder 40 47	myeloma
T11	Drug 25 36	doxorubicin
T12	Drug 67 78	thalidomide
T9	Adverse_event 57 66	receiving
E1	Adverse_event:T9 
